Corrigendum to: Comparison of Induction Therapy in Non-high Risk Acute Promyelocytic Leukemia with Arsenic Trioxide or in Combination with ATRA Leukemia Research 66 (2018) 85 –88

Regarding the survival results, please note that the 2.5-year disease free survival and overall survival in ATO group were 60% and 86% respectively and in ATO plus ATRA group, both disease-free survival and overall survival were 100%.

Source: Leukemia Research - March 20, 2018 Category: Hematology Authors: Ardeshir Ghavamzadeh, Mahdi Jalili, Sharbanoo Rostami, Marjan Yaghmaie, Leyla Sharifi Aliabadi, Seyed Asadollah Mousavi, Mohammad Vaezi, Hossein Kamranzadeh Fumani, Mohammad Jahani, Kamran Alimoghaddam Source Type: research